Atlas Trials

Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients

Clinical trial NCT03224208 · TERMINATED

Trial details

NCT number
NCT03224208
Sponsor
Fondazione Melanoma Onlus
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
MelanomaMelanoma (Skin)Melanoma Stage
Start date
2018-05-17
Primary completion
2020-09-12
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.